Published Online:
May 11, 2011
This is the protocol for a review and there is no abstract. The objectives are as follows:
Our goal is to conduct a systematic review and quantitative meta-analysis of the existing evidence from randomized controlled trials to determine the efficacy and safety of the alpha-blocker doxazosin (Cardura, Pfizer Pharmaceuticals) in men with lower urinary tract symptoms compatible with BPO.